Diastole Medical

Company Overview

Snapshot

Founded in October 2024 by Guy Masad and Dan Pri-Tal, Diastole Medical operates with 1-10 employees. The company has completed one funding round, securing pre-seed capital in July 2025.

Business overview

Diastole Medical develops AI-driven software that analyzes Doppler ultrasound signals from existing echocardiography systems. This platform supports non-invasive coronary diagnostics for healthcare providers evaluating coronary artery disease and coronary microvascular dysfunction. The technology aims to help clinicians visualize coronary flow dynamics, generate point-of-care insights, and reduce reliance on unnecessary invasive angiography, operating within the Health Tech & Life Sciences sector, specifically in Digital Medical Diagnostics and Clinical Workflow.

Company Intelligence Q&A

What is Diastole Medical's core technology?

Diastole Medical develops AI-driven software that analyzes Doppler ultrasound signals from existing echocardiography systems to support non-invasive coronary diagnostics.

When was Diastole Medical founded?

Diastole Medical was founded in October 2024.

Who are the founders of Diastole Medical?

Diastole Medical was founded by Guy Masad and Dan Pri-Tal.

What is Diastole Medical's primary market focus?

Diastole Medical focuses on healthcare providers evaluating coronary artery disease and coronary microvascular dysfunction.